| Trial ID: | L2934 |
| Source ID: | NCT04357392
|
| Associated Drug: |
Prednisone
|
| Title: |
Effect of Glucocorticoid on Exogenous Insulin Antibody Syndrome
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Prednisone
|
| Outcome Measures: |
Primary: Number of patients with HbA1c <7% at 12 and 24 weeks, 24 weeks | Secondary: Blood glucose fluctuation at 4, 12 and 24 weeks, 24 weeks
|
| Sponsor/Collaborators: |
Sponsor: chenfengling
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
EARLY_PHASE1
|
| Enrollment: |
20
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2020-05-20
|
| Completion Date: |
2023-05-20
|
| Results First Posted: |
|
| Last Update Posted: |
2020-04-24
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT04357392
|
